tirzepatide cardiovascular outcomes trial results august 2025 for Heart Failure with Preserved Ejection Fraction and Obesity tirzepatide cardiovascular outcomes trial results

Taking part is usually voluntary, but it can help improve care for others in the future

Mazdutide and tirzepatide both target weight loss as a primary outcome, addressing the global obesity epidemic impacting 1 in 8 people

doi: 10.1038/s41598-017-08055-1 123 TajimaTYoshifujiAMatsuiAItohTUchiyamaKKandaTet al

"GLP-1 side effects are common, but in my experience, they are usually manageable," says Dr

Calcium Channel Blockers These medications reduce blood pressure by relaxing the blood vessels and blocking calcium from entering heart and blood vessel cells

I felt like there was no way I could win like my body had stacked the deck against me